๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO ยท Real-Time Price ยท USD
0.2750
-0.0143 (-4.94%)
At close: Nov 19, 2026, 4:00 PM EST
0.2870
+0.0120 (4.36%)
After-hours: Nov 19, 2026, 7:30 PM EST

Mereo BioPharma Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.80.5-10-49.37
Revenue Growth
60.00%-----
Gross Profit
0.80.37-7.431.1525.13
Operating Income
-29.62-38.26-45.72-27.14-52.7-28.35
Net Income
-26.94-41.88-43.25-29.47-42.2217.23
Earnings Per Share
-0.17-0.26-0.29-0.22-0.35-0.31
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
26.140.9969.857.4268.18127.68
Total Debt
0.580.26.435.9515.3722.69
Net Cash (Debt)
25.5240.7963.3751.4752.81104.99
Net Cash Growth
-47.16%-35.63%23.13%-2.54%-49.70%1289.80%
Net Cash Per Share
0.160.260.430.390.440.95

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-22.09-30.97-32.83-21.13-48.82-7.09
Capital Expenditures
--0.02---0.01-0.72
Free Cash Flow
-22.09-30.99-32.83-21.13-48.83-7.82
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%73.40%-74.26%-50.89%
Operating Margin
-3702.50%-7651.40%--271.36%--57.42%
Pretax Margin
-3367.25%-8375.60%--299.98%-39.05%
Profit Margin
-3367.25%-8375.60%--294.66%-34.90%
FCF Margin
-2761.00%-6198.20%--211.32%--15.83%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----10.09
PS Ratio
57.26132.62-32.34-3.52